Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
Naltrexone prescribing information
Redox regulation of NF-κB p50 and M1 polarization in microglia.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium.
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
Is the treatment of multiple sclerosis headed in the wrong direction?
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Ibuprofen-induced unilateral optic neuritis.
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon Beta treatment.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Tumefactive MS lesions under fingolimod: A case report and literature review.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
Kinin-mediated inflammation in neurodegenerative disorders.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Pages
« first
‹ previous
…
201
202
203
204
205
206
207
208
209
…
next ›
last »